Port Wine Capillary Malformations: Laser Treatment and Emerging Options
Clinical Summary
Port Wine Capillary Malformation: Current Laser Standards and Emerging Therapies
-
Port wine capillary malformation: Pulsed dye laser remains the standard of care; long-pulse 532 and intense pulsed light are additional options. Early treatment—ideally within the first 1–2 weeks of life with multiple treatments during the first year—“does seem to give us a significant advantage in terms of getting clearance.”
-
Treatment selection: Lesion depth and treatment response guide laser choice. Thicker or deeper lesions may be treated with long-pulsed Alexandrite or 1064 nm lasers, but these require caution due to deeper penetration, lower hemoglobin affinity, higher energy requirements, and increased risk of injury.
-
Emerging approaches: Most lesions harbor GNAQ or GNA11 mutations, but no targeted medications are currently available. U.S. multicenter studies are evaluating intravenous photosensitizer–based photodynamic therapy, which may help resistant lesions and all skin types but requires prolonged sun avoidance and carries potential side effects.
Reviewed by Jessica Garlewicz, Managing Digital Editor of Immunology Group
Dr Kristen Kelly discusses current and emerging treatment strategies for port wine capillary malformations, including pulsed dye laser, long-pulsed 532 nm lasers, IPL, Alexandrite, and 1064 nm approaches. Learn why early treatment can improve clearance, how clinicians should tailor therapy by age, lesion depth, location, and response, and how future options such as photodynamic therapy and mutation-targeted treatments may help refractory lesions.
Transcript
I'm Kristen Kelly, and I'm a professor and chair of the Department of Dermatology at the University of California, Irvine.
What are the key differences in efficacy and limitations among current treatment options for port wine stains, particularly laser-based therapies?
Dr Kelly: So first of all, I've been trying to use the term port wine capillary malformation instead of port wine stain. The stain term can be considered derogatory. So if we're going to use that, we might use port wine birthmark a little closer. But the new International Society for the Study of Vascular Anomalies, their classification uses port wine capillary malformation to be a little more correct. So I've been trying to use that term.
In terms of different treatments, right now, really, lasers is what we have. There are a variety of different lasers. Pulsed dye laser, of course, is the classic one and can be effective in many patients, especially if we start early. We know that starting early does seem to give us a significant advantage in terms of getting clearance. And I'm talking when I say early, early in life, so hopefully the first week or two of life, and then doing multiple treatments during the first year of life.
However, there's some new data that long pulse 532 is also a very good option. Intense pulse light can also be used. And then for lesions that are deeper. So not here, I'm not talking about infants, but lesions that might be thicker or deeper. We might consider long-pulsed Alexandrite or long-pulse 1064. You do have to be more careful with those wavelengths. They go deeper. They have less affinity for the hemoglobin. So you have to use higher energy. So there is a significant risk of more injury with those deeper penetrating lasers. So you have to approach them very cautiously if you're going to use them.
In terms of alternatives, we would love to have medications, but really over the years we've studied a variety of medications to use for port wine capillary malformations, and none of them have really provided us the benefit that we would like to see for our patients. But I do think that there are things that will come down the pipeline in the next five to 10 years that hopefully will be helpful there.
And then finally, there's photodynamic therapy, which is done in China, but not in the rest of the world currently, except in studies. There is a study in the United States, a multicenter study, where people are looking at an intravenous photosensitizer with light for the port wine capillary malformations. And this is an exciting opportunity. there is more potential for side effects with this treatment especially everyone needs to stay out of the sun like in their house for at least several days and perhaps up to two weeks so you can see for many people that would be difficult but it has the opportunity to help us sometimes with some resistant lesions and then also to help us with all skin types which of course is very important as we want to give treatments to everyone.
How should clinicians approach treatment selection based on factors like patient age, lesion location, and treatment response over time?
Dr Kelly: So in terms of choosing treatment, again, the pulse dye laser is kind of our standard of care. But again, long pulse 532 is another good option. The most important thing I would say is try to get patients early so that we have the opportunity to give them the best clearance possible. If you have really resistant lesions, then sometimes we have to consider other things. And my hope is that in the future, there will be other options. Like I say, medications may be photodynamic therapy, but they're not available yet.
Are there emerging technologies or combination approaches that may improve outcomes for patients with treatment-resistant or refractory lesions?
Dr Kelly: Well, similarly, here again, I think there are the possibility of medications. Most port wine capillary malformations are a GNAQ or GNA11 mutation. And currently, we do not have medications that address those particular genetic changes. But my hope is that we'll have them in the future. And then there might be the opportunity for photodynamic therapy. Again, there may be some potential side effects. So we're going to have to consider that. But it might be an opportunity for resistant lesions.
